Jiksak is pleased to announce that it has entered into a joint research agreement with Keio University Regenerative Medicine Research Center “Director; Professor Hideyuki Okano”.
This collaboration aims to advance the development of novel therapies for neurological disorders, with a particular focus on amyotrophic lateral sclerosis (ALS) drug discovery. By combining the cutting-edge expertise and innovative technologies from both parties, the partnership seeks to open new avenues for ALS drug discovery and development. Through continued industry–academia collaboration, Jiksak remains committed to driving progress in neuroscience by promoting research and development toward overcoming intractable neurological diseases.